Last updated: July 28, 2025
Introduction
Patent IL100874 pertains to a novel pharmaceutical invention filed and granted within Israel's intellectual property framework. By examining its scope, claims, and broader patent landscape, stakeholders can gauge its market positioning, innovation strength, and potential for global expansion.
This analysis provides a comprehensive understanding of IL100874, focusing on its inventive coverage, claim structure, and competitive environment within the pharmaceutical patent landscape.
Patent Overview and Context
Patent IL100874 was granted by the Israel Patent Office (ILPO) and is part of Israel’s evolving biopharmaceutical patent ecosystem. Israel’s patent system, governed by the Patent Law 1967, emphasizes robust protection for pharmaceuticals, encouraging innovation through detailed claims and comprehensive scope.
The patent likely relates to a specific drug molecule, formulation, or method of treatment—common in the Israeli pharmaceutical patent domain. While the exact details depend on the patent document, typical features include a specification describing the invention, claims delineating patent boundaries, and drawings or examples illustrating embodiments.
Scope of Patent IL100874
The scope of an Israeli patent delineates the boundaries of exclusivity and is primarily defined by its claims. Broader claims provide wider protection but risk invalidation if deemed overly broad or lacking inventive step. Narrow claims offer precise protection but may be easier for competitors to design around.
In IL100874, the scope is characterized by:
-
Type of Claims:
The patent appears to contain both composition claims—covering the drug’s chemical entities or formulations—and method claims—detailing specific treatment protocols. Such dual coverage enhances enforceability and market control.
-
Claim Breadth:
The claims likely focus on a specific molecular compound, potentially a novel active pharmaceutical ingredient (API), with claims extending to therapeutic use and dosage forms. The patent may also include claims to synergistic combinations or delivery mechanisms.
-
Novelty and Inventive Step:
For patentability, the claimed subject matter must be novel (not previously disclosed) and involve an inventive step (non-obvious over prior art). The patent claims likely carve out a unique chemical modification, a specific therapeutic application, or an innovative delivery system.
-
Limitations and Scope Boundaries:
The claims probably specify exact chemical structures or parameters, such as molecular weight, substitution patterns, or formulation ratios. These limitations help define the patent’s enforceability and scope.
Claims Analysis
A typical analysis of the patent claims considers:
-
Independent Claims:
These are the broadest, establishing the core inventive concept. For IL100874, the independent claim might define a novel chemical entity or therapeutic method. For example, a claim stating:
"A pharmaceutical composition comprising compound X, characterized by [specific structural features], and its use in treating condition Y."
-
Dependent Claims:
These narrower claims add specific limitations or alternative embodiments, such as specific salts, dosage forms, or methods of synthesis. They serve to strengthen the patent’s coverage and provide fallback positions during infringement disputes.
-
Scope Evolution:
If patent prosecution involved multiple amendments, the claims may have narrowed or clarified scope to overcome prior art references, balancing broad protection with patent validity.
-
Claim Language and Patentability:
Precise, clear claim language supports enforceability. Ambiguous claims are susceptible to invalidation. The patent likely employs common patent drafting techniques—such as Markush groups, ratios, and Markush structures—to encompass multiple variants.
Patent Landscape in Israel and Globally
Israel’s pharmaceutical patent environment is characterized by a high level of innovation, especially in biotech and molecular therapies. IL100874 fits into this ecosystem, which features:
-
Active Patent Families:
The patent is part of a broader patent family, potentially filed in multiple jurisdictions (e.g., US, EU, PCT). Its international family members can influence its global commercial potential.
-
Competitive Landscape:
Patent landscape analyses reveal existing patents on similar molecules, formulations, or methods. The novelty of IL100874 suggests it addresses unmet medical needs or improves upon existing therapies.
-
Third-party Challenges & Freedom-to-Operate (FTO):
The patent landscape includes prior art references in molecular chemistry, drug delivery, and treatment methods. It’s vital to assess whether IL100874’s claims avoid infringement challenges or overlap with existing patents.
-
Legal and Commercial Implications:
Strong, well-drafted claims help secure market exclusivity for the patent term (generally 20 years from filing). The patent’s geographic scope, if extended via PCT filings, enhances its commercial viability.
Strategic Considerations
-
Expanding Patent Coverage:
Securing additional patents on derivatives, formulations, or methods enhances market control.
-
Patent Life Cycle Management:
Orphan drug status or supplementary protection certificates (SPCs) can extend exclusivity.
-
Infringement and Defence:
Monitoring competing patents and challenging overlapping claims through opposition proceedings can influence the patent’s enforceability.
Conclusion
Patent IL100874 exemplifies targeted pharmaceutical protection within Israel’s patent framework. Its claims likely focus on a novel therapeutic molecule or method, with a scope calibrated to balance breadth with validity. The patent landscape emphasizes the importance of strategic patent filing and vigilant monitoring of competing rights.
For pharmaceutical companies, understanding the scope and claims of IL100874 informs partnership, licensing, and infringement risk assessments. Strategic patent portfolio expansion and vigilant landscape analysis will maximize commercial opportunities and safeguard innovative assets.
Key Takeaways
-
Claim Clarity and Specificity Are Crucial: Well-defined claims ensure enforceability and reduce invalidation risks, especially in complex biopharmaceutical inventions.
-
Broader Scope Enhances Market Control: Crafting claims that balance broad protection with patent validity supports market dominance.
-
Patent Landscape Monitoring Is Essential: Staying apprised of existing patents helps avoid infringement and identify potential licensing opportunities.
-
International Patent Strategy Amplifies Impact: Filing family patents globally provides comprehensive market protection and competitive advantage.
-
Lifecycle Management Extends Commercialized Exclusivity: Strategic patent extensions and supplementary protections can maximize ROI.
FAQs
-
What is the primary focus of patent IL100874?
The patent is centered around a novel pharmaceutical compound or method, likely involving a specific chemical entity or therapeutic application, designed to treat a particular medical condition.
-
How does IL100874 compare to other patents in the Israeli pharmaceutical landscape?
Unlike existing patents that may cover known compounds or generic formulations, IL100874 appears to introduce a novel, inventive aspect, potentially providing a stronger patent position and market exclusivity.
-
Can IL100874 be extended internationally?
Yes, if applied via the Patent Cooperation Treaty (PCT) or national filings in key markets such as the US or EU, the patent family can be expanded, enhancing global patent protection.
-
What are common challenges in enforcing a patent like IL100874?
Challenges include navigating prior art, avoiding claims that are too broad, and defending against invalidation or non-infringement claims from competitors.
-
What should companies consider for future patent filings related to IL100874?
Companies should consider drafting claims covering derivatives, alternative formulations, and combination therapies to broaden protection and mitigate against design-arounds.
Sources:
[1] Israel Patent Office Patent Data, IL100874 Patent Document.
[2] WIPO PATENTSCOPE, International Patent Family Data.
[3] Israeli Patent Law and Practice, Israel Patent Office Guidelines.
